Maria Rodriguez-Barradas

Slides:



Advertisements
Similar presentations
Acceptability of early initiation of antiretrovirals for treatment as prevention among HIV-infected persons in Mochudi, Botswana Andrew Logan, PhD; Rebeca.
Advertisements

Biomarkers of Inflammation, Coagulation and Monocyte Activation Are Strongly Associated with the VACS Index among Veterans on cART Amy Justice* 1,2, Matthew.
Summary Slide Presentation Primary drug resistance in South Africa - data from 10 years of surveys Manasa J, Katzenstein D, Cassol S, Newell ML, de Oliveira.
Capture of acute myocardial infarctions occurring at non-VA hospitals by outpatient, VA Healthcare System ICD-9 codes CONCLUSIONS 1.NVH records can be.
Veterans Aging Cohort Study (VACS)
Contents - HIV global slides
Veterans Aging Cohort Study (VACS)
VACS Pulmonary & Critical Care Core
Melanie L. Fritza Ronald J. Lubelchek, MD a, b, c*
VACS Cancer Core Robert Dubrow, PhD, MD Founding Director
Long-term alcohol use patterns and HIV disease severity in U. S
VACS Physical Function & Disability Working Group
VACS Alcohol and Behavior Change Core
From: Parvovirus B19–Related Anemia in an HIV-Infected Patient: Rapid Control after Production of Neutralizing Antibodies during Highly Active Antiretroviral.
HSR Core Co-Chairs: Emily Wang, MD Kathleen McGinnis, DrPH
VACS Polypharmacy Workgroup
2009 Estimates for the HIV/AIDS epidemic in China.
Janet P. Tate, MPH, ScD Co-Director
VACS Opioids Workgroup
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
VACS Cardiovascular Disease Core
Tiffany G. Harris, PhD, MS Director of Strategic Information
VACS Uniformed Services Workgroup
Contents - HIV global slides
VACS Endocrine and Bone Workgroup
Using Laboratory Test Results at Hospital Admission to Predict Short-term Survival in Critically Ill Patients With Metastatic or Advanced Cancer  Lee.
What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?
Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008  Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,
Future challenges for clinical care of an ageing population infected with HIV: a modelling study  Dr Mikaela Smit, PhD, Kees Brinkman, MD, Suzanne Geerlings,
Age and Racial/Ethnic Differences in the Prevalence of Reported Symptoms in Human Immunodeficiency Virus-Infected Persons on Antiretroviral Therapy  Michael.
Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society.
VACS Cardiovascular Disease Core
Contents - HIV global slides
VACS Scientific Meeting 2010
The Kenya Health Behavior Study: Piloting Results
RL Cook, KA McGinnis, DA Fiellin, JH Samet, JL Goulet, S Crystal
Quality of HIV Care and Mortality in HIV-Infected Patients Who Use Drugs and Alcohol PT Korthuis, KL Kraemer, KA McGinnis, M Skanderson, AJ Gordon, AC.
Presenter Disclosure Information
Pneumococcal Polysaccharide (PV) Vaccine Failures among HIV-infected Veterans Compared to Non-HIV-infected controls. Maria C. Rodriguez-Barradas, MD.
Cholesterol Management in HIV-infected and Uninfected Patients: The Veterans Aging Cohort Study Leaf, DA, Goulet J, Goetz MB, Oursler KA, Gilbert C, Frieberg.
Kendall Bryant, PhD for the VACS Project Team RSA: July 8th, 2007
Amy C. Justice, MD, PhD For the VACS Project Team
Phenotyping Using Longitudinal VA Electronic Health Data
Update on the VACS New ART Initiator Protocol and Substudy
Integrating and Prioritizing HIV and “non HIV” Care in the cART Era
Depression Treatment in HIV-infected and Uninfected Veterans: Do Rates Vary by HIV Status? Kristen Sueoka YSM IV.
Quality of HIV Care for Veterans with Unhealthy Alcohol Use
The Kenya Health Behavior Study: Piloting Results
Farah Kidwai-Khan, Janet Tate, Cynthia Brandt, Amy Justice
HIV and Aging: The Importance of a Nuanced Approach
for the Veterans Aging Cohort Study
Veterans Aging Cohort Study Site Evaluations
Comparative Effectiveness of Alcohol and Drug Treatment in HIV Infected Veterans Kevin L. Kraemer, MD, MSc Professor of Medicine and Clinical & Translational.
The Power of Propensity Score Matching to Remove Confounding by Indication:  Statins and Acute Myocardial Infarction among HIV Infected and Uninfected.
Patterns, predictors, and consequences of non-medical use prescription opioids in the Veterans Aging Cohort Study Brandon DL Marshall, PhD Manning Assistant.
Shawn L Fultz, MD MPH VACS Scientific Meeting, Feb 2004
VACS Antiviral Workgroup
Jeffrey P. Anderson Combination Antiretroviral Therapy and Hepatic Decompensation in HIV/HCV Coinfected Veterans JEFFREY P. ANDERSON.
Cross CHAART Working Groups
VACS Mental Health WG Joseph L. Goulet, PhD, MS Director
VACS Scientific Meeting Houston, TX February 2004
for the VACS Project Team
Update on the VACS HIV CVD Substudy and Preliminary Analyses
Biostatistics Core Members Joyce Chang Kirsha Gordon Joseph Goulet
Lung Diseases in HIV-infected Veterans
Melissa Herrin, Jan Tate ScD, MPH & Amy Justice, MD, PhD
VACS Scientific Meeting 2016
Trends in the incidence, treatment, and outcomes of acute lower extremity ischemia in the United States Medicare population  Donald T. Baril, MD, Kaushik.
Contents - HIV global slides
VACS Statins Workgroup
Presentation transcript:

Maria Rodriguez-Barradas VACS Index Workgroup Amy Justice, MD, PhD Co-Director Members Kathleen Akgun Sheldon Brown Kendall Bryant Joyce Chang Matthew Freiberg Cynthia Gibert Matthew Goetz Vincent Marconi Kathleen McGinnis Kris Ann Oursler David Rimland Maria Rodriguez-Barradas Janet Tate, ScD Co-Director

Summary of Activities Key publications An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS. 2013;27(4):563-72. Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. JAIDS. 2013;62(2):149-63. The VACS Index predicts mortality in a young, healthy HIV population starting highly active antiretroviral therapy. JAIDS. 2014;65(2):226-30. The VACS index accurately predicts mortality and treatment response among multi-drug resistant HIV infected patients participating in the OPTIMA study. PLoS One. 2014;9(3):e92606. Association of the VACS Index with exercise capacity in HIV-infected adults. AIDS Res Hum Retroviruses. 2013;29(9):1218-23. Current work Version 2.0 30 day outcomes in uninfected, hospitalized patients Yale, New York University, U. Pennsylvania